financetom
Business
financetom
/
Business
/
Hearing Solutions to utilise ₹50 crore fundraise for nationwide expansion, says managing director
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hearing Solutions to utilise ₹50 crore fundraise for nationwide expansion, says managing director
Nov 20, 2023 11:22 AM

Hearing Solutions, the company behind the Hearzap hearing care chain, has successfully secured ₹50 crore in funding from the healthcare and life sciences-focused private equity fund of 360 One Asset Management.

S Raja, Managing Director of Hearing Solutions, expressed the company's strategic plans for the newly acquired funds, stating, "We plan to utilise these funds for spreading awareness through digital platforms and increase our footprint across the country."

Hearzap specialises in providing hearing care solutions and has developed a digital suite of audiology applications for remote diagnosis and virtual shopping of hearing care devices.

Raja highlighted that the company aims to reach revenue of ₹100 crore by next year. Last year the company did revenue of ₹60 crore and is looking to hit revenue of ₹75 crore in the current year.

The Hyderabad-headquartered startup also aims to increase its store count from 90 to 150 by the end of the next calendar year.

The company also has plans to launch partner-owned, company-operated stores to engage with a broader audience, especially in Tier II and Tier III cities.

Additionally, Param Gandhi, Co-Founder of Fibmold, and Reihem Roy, Partner at Omnivore, share insights into the future plans of Fibmold, a startup founded in 2022 that focuses on sustainable packaging.

Fibmold recently raised $10 million and specialises in developing eco-friendly molded fiber packaging products, providing alternatives to single-use plastic in various industries.

According to Gandhi, a significant portion of the raised capital will be dedicated to establishing a pilot manufacturing plant. Moreover, a certain amount will be invested in research and development initiatives and team building.

Watch the accompanying video for the entire discussion

(Edited by : Ajay Vaishnav)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved